Tag: Robert M Davis

Merck to acquire Imago BioSciences to expand blood disorder drugs portfolio

Raghuram Kadari- November 23, 2022

Pharma giant Merck will acquire Imago BioSciences, a Nasdaq-listed clinical stage biopharmaceutical company, for a price of $36 per share in cash, which translates to ... Read More